Christian Gilbert J Wolff

Title: Christian Gilbert J Wolff: Innovator in Pain Modulation

Introduction

Christian Gilbert J Wolff is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pain modulation through his innovative patents. With a total of six patents to his name, Wolff's work focuses on the development of pharmaceutical compositions that target ion channels involved in pain perception.

Latest Patents

Wolff's latest patents include a Na1.7 binding entity that functionally modifies the activity of the ion channel. This includes an anti-Na1.7 antibody or binding fragment, along with pharmaceutical compositions comprising these antibodies. His work emphasizes the use of these antibodies in the treatment and modulation of pain, as well as the processes for generating and preparing these antibodies. Another significant patent involves a method of treating a patient for pain by administering an anti-ion channel antibody, specifically an anti-E1 ion channel antibody or binding fragment thereof.

Career Highlights

Throughout his career, Christian Gilbert J Wolff has worked with prominent companies in the pharmaceutical industry, including UCB Pharma and UCB Biopharma. His experience in these organizations has allowed him to develop and refine his innovative approaches to pain treatment.

Collaborations

Wolff has collaborated with notable colleagues such as Karen Margrete Miller and Marc Roger De Ryck. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Christian Gilbert J Wolff stands out as an influential inventor in the realm of pain modulation. His innovative patents and collaborations reflect his commitment to advancing medical treatments for pain management.